{"page_content": "73\nSASB TOPIC\nACTIVITY METRICREPORTING\nREPORTINGUNIT OF \nMEASURE\nUNIT OF \nMEASURECODE\nCODETotal amount of monetary losses as a \nresult of legal proceedings associated \nwith corruption and briberyAmgen discloses material, legal, and regulatory \nissues in its annual 10-K and quarterly 10-Qs\nAmgen regularly reports market segment share \nas part of its earnings calls and in its earnings \nreleases that are furnished on Form 8-KReporting \ncurrency\nNumberHC-BP-510a.1\nHC-BP-000.ADescription of code of ethics \ngoverning promotion of off-label \nuse of productsSee our policy on Communications with \nMembers of the Healthcare Community\nPertinent reporting can be found in the Products \nand Pipeline sections on our website and the \nBusiness section of Part I of our 10-Kn/a\nNumberHC-BP-510a.2\nHC-BP-000.B\nBusiness \nEthics\nNumber of patients treated\nNumber of drugs (1) in portfolio and (2) in research \nand development (Phases 1-3)ACTIVITY METRICSThe inclusion of information contained in this disclosure \nshould not be construed as a characterization regarding the \nmateriality or financial impact of that information. Please also \nsee our filed Form 10-K, and other publicly filed documents \navailable at https://investors.amgen.com/financials/sec-filings. \nThis report contains information about Amgen and may \ncontain forward-looking statements within the meaning of \nthe Private Securities Litigation Reform Act. All statements, \nother than statements of historical facts, may be forward-\nlooking statements. Amgen cautions that forward-looking \nstatements are subject to numerous assumptions, risks and \nuncertainties, which change over time. Forward-looking \nstatements speak only as of the date they are made, and \nAmgen assumes no duty to and does not undertake to \nupdate forward-looking statements. Actual results could \ndiffer materially from those anticipated in forward-looking \nstatements, and future results could differ materially from \nhistorical performance. Factors that can cause results to \ndiffer, as well as additional factors that can affect forward-\nlooking statements, are discussed in Amgen\u2019s Annual \nReport on Form 10-K and Quarterly Reports on Form 10-Q, \naccessible on the SEC\u2019s website at www.sec.gov and on \nAmgen\u2019s investor website at https://investors.amgen.com/ \nand https://investors.amgen.com/financials/sec-filings.APPENDIX INTRODUCTION GOVERNANCECOVID- 19 \nRESPONSEBUSINESS \nETHICSETHICAL \nRESEARCHACCESS TO \nMEDICINEDIVERSITY, INCLUSION, \nAND BELONGINGENVIRONMENTAL\nSUSTAINABILITYRESPONSIBLE \nSOURCINGCOMMUNITY \nINVESTMENT\nACCOUNTING METRIC", "metadata": {"source": "NASDAQ_AMGN_2020.pdf", "page": 72, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}